Hyperhomocysteinemia in Tunisian bipolar i patients

Psychiatry and Clinical Neurosciences

Volumn 65, Issue 7, 2011, Pages 664-671

  Ezzaher, Asma ^a   Mouhamed, Dhouha Haj ^a   Mechri, Anwar ^a   Omezzine, Asma ^b   Neffati, Fadoua ^a   Douki, Wahiba ^a   Bouslama, Ali ^b   Gaha, Lotfi ^a   Najjar, Mohamed Fadhel ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

bipolar I disorder; folate; homocysteine; MTHFR C677T polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CARBAMAZEPINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; BIPOLAR I DISORDER; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; TUNISIA; VITAMIN BLOOD LEVEL;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD+); MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; TUNISIA; VITAMIN B 12;

EID: 84255190963     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2011.02284.x     Document Type: Article

References (28)

1. Osher Y, Bersudsky Y, Silver H, et al,. Neuropsychological correlates of homocysteine levels in euthymic bipolar patients. J. Affect. Disord. 2008; 105: 229-233. (Pubitemid 350245682)
2. Lee ES, Chen H, Soliman KF, et al,. Effects of homocysteine on the dopaminergic system and behavior in rodents. Neurotoxicology 2005; 26: 361-371. (Pubitemid 40780013)
3. Greene JG,. Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease. J. Physiol. 2006; 575: 411-416. (Pubitemid 44270172)
4. Vuksan-Ausa B, JakovljeviA M, Åagud M, et al,. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA. Psychiatry Res. 2011; 189: 21-25.
5. Frosst P, Blom HJ, Milos R, et al,. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995; 10: 111-113.
6. Dierkes J, Westphal S,. Effect of drugs on homocysteine concentrations. Semin. Vasc. Med. 2005; 5: 124-139. (Pubitemid 40944288)
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC, 2004.
8. World Health Organization. Obesity: Preventing and Managing the Global Epidemic (publication WHO/NUT/NCD/98.1). World Health Organization, Geneva, 1997.
9. Miller SA, Dykes DD, Polesky HF,. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
10. Belkahla R, Omezzine A, Kchok K, et al,. Effet des polymorphismes des enzymes clés du métabolisme de l'homocystéine sur l'homocystéinémie et le risque coronarien chez une population tunisienne. Ann. Cardiol. Angeiol. 2008; 57: 219-224.
11. Ipcioglu OM, Ozcan O, Gultepe M, et al,. Reduced urinary excretion of homocysteine could be the reason of elevated plasma homocysteine in patients with psychiatric illnesses. Clin. Biochem. 2008; 41: 831-835.
12. Mill J, Tang T, Kaminsky Z, et al,. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 2008; 82: 696-711. (Pubitemid 351726115)
13. Atmaca M, Tezcan E, Kulolu M, et al,. Serum folate and homocysteine levels in patients with obsessive-compulsive disorder. Psychiatry Clin. Neurosci. 2005; 59: 616-620. (Pubitemid 41765764)
14. Reif A, Pfuhlmann B, Lesch KP,. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29: 1162-1168. (Pubitemid 41383515)
15. Tolmunen T, Hintikka J, Voutilainen S, et al,. Association between depressive symptoms and serum concentrations of homocysteine in men: A population study. Am. J. Clin. Nutr. 2004; 80: 1574-1578. (Pubitemid 41103856)
16. Reynolds E,. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006; 5: 949-960. (Pubitemid 44556551)
17. Mennen LI, Potier de Courcy G, Guilland JC, et al,. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am. J. Clin. Nutr. 2002; 76: 1279-1289. (Pubitemid 35416563)
18. Ozbek Z, Kucukali CI, Ozkok E, et al,. Effect of the methylenetetrahydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008; 32: 1331-1337.
19. Kunugi H, Fukuda R, Hattori M, et al,. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol. Psychiatry 1998; 5: 435-437. (Pubitemid 28442418)
20. Kempisty B, Mostowska A, Gorska I, et al,. Association of 677CNT polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia. Neurosci. Lett. 2006; 3: 267-271.
21. Kempisty B, Bober A, Luczak M, et al,. Distribution of 1298ANC polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia. Eur. Psychiatry 2007; 1: 39-43. (Pubitemid 46162184)
22. Cohen-Woods S, Craig I, Gaysina D, et al,. The Bipolar Association Case-Control Study (BACCS) and meta-analysis: No association with the 5,10-methylenetetrahydrofolate reductase gene and bipolar disorder. Am. J. Med. Genet. B. 2010; 153B: 1298-1304.
23. Gilbody S, Lewis S, Lightfoot T,. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. Am. J. Epidemiol. 2007; 165: 1-13. (Pubitemid 46026203)
24. Zintzaras E,. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: A meta-analysis of genetic association studies. Psychiatr. Genet. 2006; 16: 105-115. (Pubitemid 44502772)
25. Peerbooms OLJ, Van Os J, Drukker M, et al,. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: Evidence for a common genetic vulnerability? Brain Behav. Immun. 2011; 25: 1530-1543.
26. Hasanah CI, Khan UA, Musalmah M, et al,. Reduced red-cell folate in mania. J. Affect. Disord. 1997; 46: 95-99. (Pubitemid 28037481)
27. Ono H, Sakamoto A, Eguchi T, et al,. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsant. Metabolism 1997; 46: 959-962. (Pubitemid 27339924)
28. Sener U, Zorlu Y, Karaguzel O, et al,. Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6. Seizure 2006; 15: 79-85. (Pubitemid 43192416)